Literature DB >> 17959251

Modulation of pain transmission by G-protein-coupled receptors.

Hui-Lin Pan1, Zi-Zhen Wu, Hong-Yi Zhou, Shao-Rui Chen, Hong-Mei Zhang, De-Pei Li.   

Abstract

The heterotrimeric G-protein-coupled receptors (GPCR) represent the largest and most diverse family of cell surface receptors and proteins. GPCR are widely distributed in the peripheral and central nervous systems and are one of the most important therapeutic targets in pain medicine. GPCR are present on the plasma membrane of neurons and their terminals along the nociceptive pathways and are closely associated with the modulation of pain transmission. GPCR that can produce analgesia upon activation include opioid, cannabinoid, alpha2-adrenergic, muscarinic acetylcholine, gamma-aminobutyric acidB (GABAB), groups II and III metabotropic glutamate, and somatostatin receptors. Recent studies have led to a better understanding of the role of these GPCR in the regulation of pain transmission. Here, we review the current knowledge about the cellular and molecular mechanisms that underlie the analgesic actions of GPCR agonists, with a focus on their effects on ion channels expressed on nociceptive sensory neurons and on synaptic transmission at the spinal cord level.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17959251      PMCID: PMC2965406          DOI: 10.1016/j.pharmthera.2007.09.003

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  322 in total

1.  CB2 cannabinoid receptor-mediated peripheral antinociception.

Authors:  T P Malan; M M Ibrahim; H Deng; Q Liu; H P Mata; T Vanderah; F Porreca; A Makriyannis
Journal:  Pain       Date:  2001-09       Impact factor: 6.961

Review 2.  G-protein-coupled receptors at a glance.

Authors:  Wesley K Kroeze; Douglas J Sheffler; Bryan L Roth
Journal:  J Cell Sci       Date:  2003-12-15       Impact factor: 5.285

Review 3.  Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.

Authors:  Kurt Kristiansen
Journal:  Pharmacol Ther       Date:  2004-07       Impact factor: 12.310

4.  Intrathecal alpha 2-adrenergic agonists stimulate acetylcholine and norepinephrine release from the spinal cord dorsal horn in sheep. An in vivo microdialysis study.

Authors:  W Klimscha; C Tong; J C Eisenach
Journal:  Anesthesiology       Date:  1997-07       Impact factor: 7.892

5.  M2, M3 and M4, but not M1, muscarinic receptor subtypes are present in rat spinal cord.

Authors:  A U Höglund; H A Baghdoyan
Journal:  J Pharmacol Exp Ther       Date:  1997-04       Impact factor: 4.030

6.  Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo.

Authors:  S Kelly; V Chapman
Journal:  J Neurophysiol       Date:  2001-12       Impact factor: 2.714

7.  Assignment of muscarinic receptor subtypes mediating G-protein modulation of Ca(2+) channels by using knockout mice.

Authors:  M S Shapiro; M D Loose; S E Hamilton; N M Nathanson; J Gomeza; J Wess; B Hille
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

8.  G(o) transduces GABAB-receptor modulation of N-type calcium channels in cultured dorsal root ganglion neurons.

Authors:  A S Menon-Johansson; N Berrow; A C Dolphin
Journal:  Pflugers Arch       Date:  1993-11       Impact factor: 3.657

9.  Epidural somatostatin as an analgesic in upper abdominal surgery: a double-blind study.

Authors:  Pilar Taurà; Vicente Planella; Jaume Balust; Joan Beltran; Teresa Anglada; Enrique Carrero; Sebastián Burgués
Journal:  Pain       Date:  1994-10       Impact factor: 6.961

10.  Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.

Authors:  C C Felder; K E Joyce; E M Briley; J Mansouri; K Mackie; O Blond; Y Lai; A L Ma; R L Mitchell
Journal:  Mol Pharmacol       Date:  1995-09       Impact factor: 4.436

View more
  70 in total

Review 1.  Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.

Authors:  Claire Gavériaux-Ruff; Brigitte Lina Kieffer
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

2.  Dopaminergic amacrine cells express opioid receptors in the mouse retina.

Authors:  Shannon K Gallagher; Julia N Anglen; Justin M Mower; Jozsef Vigh
Journal:  Vis Neurosci       Date:  2012-05       Impact factor: 3.241

3.  Ondansetron reverses antihypersensitivity from clonidine in rats after peripheral nerve injury: role of γ-aminobutyric acid in α2-adrenoceptor and 5-HT3 serotonin receptor analgesia.

Authors:  Ken-ichiro Hayashida; Masafumi Kimura; Masaru Yoshizumi; Shotaro Hobo; Hideaki Obata; James C Eisenach
Journal:  Anesthesiology       Date:  2012-08       Impact factor: 7.892

Review 4.  Behavioral and Genetic Evidence for GIRK Channels in the CNS: Role in Physiology, Pathophysiology, and Drug Addiction.

Authors:  Jody Mayfield; Yuri A Blednov; R Adron Harris
Journal:  Int Rev Neurobiol       Date:  2015-06-22       Impact factor: 3.230

5.  Blockade of α2-adrenergic or metabotropic glutamate receptors induces glutamate release in the locus coeruleus to activate descending inhibition in rats with chronic neuropathic hypersensitivity.

Authors:  Ken-Ichiro Hayashida; Masafumi Kimuram; James C Eisenach
Journal:  Neurosci Lett       Date:  2018-04-05       Impact factor: 3.046

Review 6.  In search of analgesia: emerging roles of GPCRs in pain.

Authors:  Laura S Stone; Derek C Molliver
Journal:  Mol Interv       Date:  2009-10

7.  Diabetic neuropathy enhances voltage-activated Ca2+ channel activity and its control by M4 muscarinic receptors in primary sensory neurons.

Authors:  Xue-Hong Cao; Hee Sun Byun; Shao-Rui Chen; Hui-Lin Pan
Journal:  J Neurochem       Date:  2011-09-21       Impact factor: 5.372

8.  Direct interaction of GABAB receptors with M2 muscarinic receptors enhances muscarinic signaling.

Authors:  Stephanie B Boyer; Sinead M Clancy; Miho Terunuma; Raquel Revilla-Sanchez; Steven M Thomas; Stephen J Moss; Paul A Slesinger
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

9.  High-Intensity Swimming Exercise Decreases Glutamate-Induced Nociception by Activation of G-Protein-Coupled Receptors Inhibiting Phosphorylated Protein Kinase A.

Authors:  Daniel F Martins; Aline Siteneski; Daniela D Ludtke; Daniela Dal-Secco; Adair R S Santos
Journal:  Mol Neurobiol       Date:  2016-09-13       Impact factor: 5.590

10.  Endothelin-A receptor antagonism attenuates carcinoma-induced pain through opioids in mice.

Authors:  Phuong N Quang; Brian L Schmidt
Journal:  J Pain       Date:  2010-01-13       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.